Prostate cancer is usually diagnosed before it has any effect.
Prostate cancer does not usually produce symptoms. Most of the time it is diagnosed before it has any effect. Its main risk factor for developing it is age.
Prostate cancer does not usually produce symptoms. Most of the time it is diagnosed before it has any effect. The manifestations that a man with a prostate tumor usually presents are secondary to benign prostatic hyperplasia, which usually coexists with it:
In some cases, prostate cancer may debut in advanced stages. On these occasions, the tumor may cause local symptoms such as:
The causes of prostate cancer are not known but the main risk factor for developing it is age. There are some associations between racial factors (more common in blacks) with increased diagnosis of prostate cancer. In addition, there seems to be a clear association between some mutations, such as carriers of the BRCA1 and BRCA2 genes, and the possibility of developing prostate cancer.
On the other hand, there seem to be dietary factors, such as obesity, diabetes, alcohol consumption, excessive consumption of red meat and diets with a high percentage of fatty, fried, dairy and processed foods.
Tomato, lycopenes and soy appear to be protective. The relationship between some micronutrients (Selenium and Vitamin E) with prostate tumor development is debatable.
Robotic surgery is recommended in a variety of situations where its advantages can significantly improve patient outcomes compared to traditional open or laparoscopic surgery. It is considered especially beneficial in complex procedures where high precision and surgical dexterity are required in confined spaces, in patients with comorbidities and/or when urinary or erectile function is sought to be preserved.
It is normal to bleed after a prostate biopsy for one to two weeks, depending on the type of bleeding. There may be blood in the urine, stool and/or semen.
At the age of 50 it is advisable to have a PSA, a blood test to measure the Prostate Specific Antigen that helps to detect possible abnormalities in the prostate. If you have a family history of breast or prostate cancer, it is recommended to start screening at around 45 years of age due to the increased risk associated with prostate cancer.
It is sufficient to perform PSA and a digital rectal examination -especially if the PSA is higher than 2.5-. On some occasions ultrasound, flowmetry or even genetic tests can be performed to study different aspects of the prostate.
Salvage lymph node dissection in patients with prostate cancer treated with radical prostatectomy or radiotherapy and positive choline positron emission tomography (PET/CT) scan